STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 54 filers reported holding STOKE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $45,238,000 | +73.3% | 1,343,956 | +100.0% | 0.29% | -10.9% |
| Q1 2021 | $26,100,000 | -37.3% | 671,978 | 0.0% | 0.33% | -26.2% |
| Q4 2020 | $41,616,000 | +84.9% | 671,978 | 0.0% | 0.45% | +35.9% |
| Q3 2020 | $22,505,000 | +40.5% | 671,978 | 0.0% | 0.33% | +27.0% |
| Q2 2020 | $16,013,000 | +4.1% | 671,978 | 0.0% | 0.26% | -35.4% |
| Q1 2020 | $15,388,000 | -19.1% | 671,978 | 0.0% | 0.40% | +6.1% |
| Q4 2019 | $19,030,000 | +31.8% | 671,978 | 0.0% | 0.38% | -2.8% |
| Q3 2019 | $14,440,000 | -26.3% | 671,978 | 0.0% | 0.39% | -13.6% |
| Q2 2019 | $19,601,000 | – | 671,978 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |